	Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline. Alzheimers Dement Zhang J, Zhang J, Ding J, Zhang X, Wang Y, Wei W, Chai Y, Zhang S, Chen X. PMID: 42151696 [PubMed - in process]
	Physical activity, aerobic fitness, and AD blood biomarkers: The IGNITE study. Alzheimers Dement Oberlin LE, Solis-Urra P, Sewell KR, Collins AM, Kang C, Huang H, Grove G, Wan L, Kramer AF, McAuley E, Burns JM, Hillman CH, Vidoni ED, Marsland AL, Kamboh MI, Szabo-Reed A, Rogers RJ, Morris J, Zeng X, Karikari TK, Jakicic JM, Erickson KI. PMID: 42151104 [PubMed - indexed for MEDLINE]
	Peripheral biomarkers of neuroinflammation in Alzheimer's disease and vascular dementia. Biochem Pharmacol Ouyang X, Chia RSL, Chai YL, Chong JR, Sim MA, Jo DG, Arumugam TV, Sethi G, Dawe GS, Chen CP, Lai MKP. PMID: 42150695 [PubMed - as supplied by publisher]
	Explainable machine learning for predicting longitudinal dementia status: Establishing a leakage-free benchmark. PLOS Digit Health Ghiasi MM, Falck RS, Liu-Ambrose T, Tam RC. PMID: 42149898 [PubMed]
	Facilitating the measurement and treatment of Behavioral and Psychological Symptoms of Dementia (BPSD) and understanding caregiver burden using wearable devices in Rural Taiwan-Protocol for a dyadic feasibility pilot study. PLoS One Guu TW, Li WJ, Lee SH, Hsu CS, Chou CN, Lack L, Ma WF. PMID: 42149841 [PubMed - indexed for MEDLINE]
	Montefiore Einstein Robust Geriatric Normative Project (MERGER-NP): standardized regression-based formulas and multivariate base rates for evaluating cognitive change. Arch Clin Neuropsychol Freilich BM, Holtzer R. PMID: 42149681 [PubMed - indexed for MEDLINE]
	Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials. JAMA Neurol Flanders MD, Caunca M, La Joie R, Schneider LS, Ackley SF. PMID: 42149605 [PubMed - as supplied by publisher]
	Development of 5-year risk prediction models for incident dementia and mortality in a community-dwelling older Japanese population: The Japan Prospective Studies Collaboration for Aging and Dementia (JPSC-AD). Geroscience Meng X, Honda T, Ohara T, Furuta Y, Shibata M, Hata J, Taki Y, Mikami T, Maeda T, Ono K, Mimura M, Hanajima R, Iga JI, Takebayashi M, Ninomiya T, On the behalf of the JPSC-AD study group. PMID: 42149314 [PubMed - as supplied by publisher]
	The Copper-Gut-Brain Axis: A Triple Inflammatory Pathway Driving Neuroinflammation in Alzheimer's Disease. Aging Dis Ambi A. PMID: 42149101 [PubMed - as supplied by publisher]
	Therapeutic Landscape of Early Symptomatic Alzheimer's Disease Translated into Everyday Practice for Geriatric Providers. Clin Interv Aging Bailey-Taylor MJ, Morrow P, Hendrix J, Galluzzi KE, Sharafsaleh G. PMID: 42148368 [PubMed - indexed for MEDLINE]
	Development of coumarin-sulfonate scaffolds for cholinesterase inhibition: experimental and computational studies toward Alzheimer's disease therapy. RSC Adv Mughal EU, Naeem N, Cheema AS, Othman GA, Sadiq A, Bayrak S, K, Hawsawi MB, Gomha SM, Almaz Z. PMID: 42148273 [PubMed]
	Anti-AÎ²3-10 monoclonal antibody 7B8 improves cognitive function and protects the blood-brain barrier in APP/PS1 mice by regulating the HMGB-1/RAGE/NF-ÎºB pathway. Front Immunol You J, Liu Q, Li X. PMID: 42148080 [PubMed - indexed for MEDLINE]
	The adaptation and evaluation of a culturally grounded lifestyle intervention to mitigate the risk of Alzheimer's disease and related dementias in Native Hawaiians and Pacific Islanders: A study protocol. SSM Ment Health Kaholokula JK, Buchwald D, MacLehose R, Look M, de Silva M, Worthington Antonio JK, Desimone K, Yoshimura S, Dillard A, Kenney M, Keali, Purdy M. PMID: 42147774 [PubMed]
	Genetic variation in the glymphatic pathway predicts cognition and neurodegeneration in preclinical Alzheimer's disease. Res Sq Armstrong AM, O'Brien EK, Fernandez SM, Doré V, Bourgeat P, Shishegar R, Maruff P, Rowe CC, Villemagne VL, Initiative TADN, Group TAR, Porter T, Laws SM. PMID: 42147167 [PubMed]
	A Cell-Type-Resolved Meta-Analysis Reveals Glial DNA Methylation Changes Associated with Aging and Alzheimer's Disease. bioRxiv Bhaskar U, Kos MZ, Carless MA. PMID: 42146576 [PubMed]
	A diagnostic plasma omics-biomarker for Alzheimer's disease informed by microglial single-cell transcriptomics: A pilot study. bioRxiv Lutz MW, Man Z, Zheng Y, Venkatesan S, Chiba-Falek O. PMID: 42146366 [PubMed]
	Epigenetic Modulation Is a Key Mechanism in Cognitive Deficit: Unveiling Garcinol as a Potent HAT Inhibitor in Improving Alzheimer's Disease. ACS Omega Mishra A, Satapathy BS, Sahu PK, Ghose A, Paidesetty SK. PMID: 42146238 [PubMed]
	A data-driven Alzheimer's disease progression simulator for retrospective validation and prospective Phase III power design. medRxiv Lorenzi M, Custo A, Frisoni GB, Garibotto V. PMID: 42145636 [PubMed]
	A Genome-wide Association Study of Alzheimer's Disease and Dementia in a Large Multi-ancestry Military Cohort Identifies Many New Dementia-Associated Loci. medRxiv Sherva R, Bayly H, Zhang R, Harrington K, Mez J, Miller MW, Tsuang D, Wolf E, Zeng Q, Le Guen Y, Tejeda M, VA Million Veteran Program, MVP Cognitive Decline, Dementia During Aging Working Group, Gaziano JM, Panizzon MS, Hauger RL, Merritt VC, Farrer LA, Logue MW. PMID: 42145619 [PubMed]
	Multi-Target-Directed Ligands (MTDLs) as Potential Therapeutic Candidates Targeting Multiple Pathogenic Factor of Alzheimer's Disease. CNS Neurosci Ther Jung J, Kim Y, Cirunduzi AC, Yoon S, Bang S, Yang SH. PMID: 42145047 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 125030

Page 1 of 6252



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy